Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact of DLI after In Vivo T-Cell-Depletion: Prophylactic CD8 Depleted or Preemptive CD3pos DLI?

Lorena Eichholz, Beate Hautprock, MD, Daniela Wehler, MD, Wolfgang Herr, MD, Ralf Georg Meyer, MD, Matthias Theobald, MD, Eva Maria Wagner, MD

Blood (2016) 128 (22): 2292.

https://doi.org/10.1182/blood.V128.22.2292.2292

Published: 2016

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Ralf G. Meyer, Cedrik M. Britten, Daniela Wehler, Klaus Bender, Georg Hess, Abdo Konur, Udo F. Hartwig, Thomas C. Wehler, Andrew J. Ullmann, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, Wolfgang Herr

Blood (2006) 109 (1): 374–382.

https://doi.org/10.1182/blood-2006-03-005769

Published: 2006

Journal Articles

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Ralf G. Meyer, MD, Cedrik M. Britten, MD, Abdo Konur, PhD, Klaus Bender, PhD, Daniela Wehler, MD, Udo Hartwig, PhD, Thomas C. Wehler, MD, Chiara Gentilini, MD, Lutz Uharek, MD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2005) 106 (11): 297.

https://doi.org/10.1182/blood.V106.11.297.297

Published: 2005

Journal Articles

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Ralf G. Meyer, MD, Daniela Wehler, MD, Thomas C. Wehler, MD, Cedrik M. Britten, MD, Alexander Burchardt, MD, Udo Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2004) 104 (11): 5069.

https://doi.org/10.1182/blood.V104.11.5069.5069

Published: 2004

NARROW

Impact of DLI after In Vivo T-Cell-Depletion: Prophylactic CD8 Depleted or Preemptive CD3pos DLI?

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Email alerts

ASH Publications

American Society of Hematology

Impact of DLI after In Vivo T-Cell-Depletion: Prophylactic CD8 Depleted or Preemptive CD3pos DLI?

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only